Welcome to our dedicated page for Cbdmd news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on Cbdmd stock.
cbdMD, Inc. (NYSE American: YCBD) generates a steady flow of corporate, financial, and strategic news tied to its position in the hemp-derived wellness and cannabinoid products space. Company press releases and SEC filings highlight developments across its cbdMD and Paw CBD brands, ATRx Labs functional mushroom products, and Herbal Oasis hemp-derived THC social seltzers, as well as capital markets activity and exchange-listing matters.
News for YCBD often covers operating performance, including updates on net sales, gross profit, and operating loss trends disclosed in conjunction with annual and quarterly results. The company has reported multiple years of operating improvement and has discussed cost management, product portfolio optimization, and marketing investments in its communications. Investors following YCBD news also see disclosures about preferred stock financings, such as Series B and Series C Convertible Preferred Stock, and the establishment of an equity line of credit registered on Form S-1.
Regulatory and listing-related announcements form another key part of cbdMD’s news flow. The company has reported regaining full compliance with NYSE American continued listing standards after addressing equity-related deficiencies, and it has furnished related information through Form 8-K filings. Policy commentary around federal discussions on cannabinoids and hemp-derived products, and how those discussions may affect research and investment in the category, also appears in its releases.
Strategic updates, including the asset acquisition of Gaia Botanicals, LLC and its Bluebird Botanicals brand and online CBD marketplace, are disclosed through press releases and 8-K filings. These items provide detail on how cbdMD is expanding its brand portfolio, intellectual property base, and product offerings in CBD and related categories. For investors and observers, the YCBD news page offers a centralized view of earnings communications, capital transactions, regulatory milestones, and brand-level initiatives across cbdMD’s wellness platform.
cbdMD, Inc. (NYSE American: YCBD) has announced the launch of its direct-to-consumer operations in the United Kingdom, featuring a dedicated website for U.K. customers. This expansion follows a partnership with Ultra Sport EU for comprehensive distribution. U.K. consumers can now purchase cbdMD's popular products, including CBD oil tinctures, softgel capsules, and gummies, with fulfillment from a local warehouse. co-CEO Martin Sumichrast emphasized the growing demand for CBD products globally, positioning this launch as a significant growth opportunity in the U.K. market.
cbdMD, Inc. (YCBD) reported financial results for Q4 and fiscal year 2020, indicating significant growth with a 77% year-over-year increase in net sales, reaching $41.9 million. E-commerce sales surged by 106% to $30.5 million, accounting for 73% of total sales. The company achieved a notable decrease in non-GAAP adjusted loss from operations to approximately $1.3 million in the second half of the year. Despite a net income of $12.2 million, operational losses persisted. A cash position of about $30 million supports the 2021 strategy, as the company aims for positive adjusted operating income.
cbdMD, Inc. (NYSE American: YCBD) will host a conference call on December 22, 2020, at 4:15 p.m. ET to discuss its financial results for the fourth quarter and fiscal year ending September 30, 2020. The call will provide insights into the company's performance and business progress. Domestic and international dial-in numbers are included for participants. The replay will be available through January 20, 2021, and a webcast link for replay is also provided.
cbdMD announced an expansion of its product offerings at Save Mart, increasing from five to 100 locations across California and Northern Nevada. This decision comes as a result of strong retail sales performance of cbdMD and Paw CBD brands. Pancho Mangual, EVP of Sales, emphasized that retailers are responding positively to excellent sell-through results. cbdMD, recognized for its variety of CBD products, aims to leverage this partnership for greater market share.